Report cover image

Global Hepatitis A Vaccine Market Insights, Forecast to 2028

Publisher QYResearch Group
Published Mar 01, 2022
Length 145 Pages
SKU # QYR17024596

Description

Global Hepatitis A Vaccine Market Insights, Forecast to 2028

Summary

Market Analysis and Insights: Global Hepatitis A Vaccine Market
Due to the COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 735.86 million in 2022 and is forecast to a readjusted size of US$ 840.42 million by 2028 with a CAGR of 2.24% during the review period.
The global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, and AIM Vaccine etc. In 2021, the global top five players have a share approximately 81.09% in terms of revenue.
Global Hepatitis A Vaccine Scope and Segment
Hepatitis A Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
AIM Vaccine

Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Segment by Application
Government Institution
Private Sector
Other

Segment by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

Table of Contents

145 Pages
1 STUDY COVERAGE
1.1 Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.4 Study Objectives
1.5 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis A Vaccine Sales by Region
2.4.1 Global Hepatitis A Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis A Vaccine by Region (2023-2028)
2.5 Global Hepatitis A Vaccine Revenue by Region
2.5.1 Global Hepatitis A Vaccine Revenue by Region (2017-2022)
2.5.2 Global Hepatitis A Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 South America
2.10 Middle East & Africa
3 COMPETITION BY MANUFACTURERS
3.1 Global Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Global Hepatitis A Vaccine Sales by Manufacturers (2020-2022)
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2022)
3.1.3 Global Top Largest Manufacturers of Hepatitis A Vaccine in 2021
3.2 Global Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2020-2022)
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2022)
3.2.3 Global Top Companies by Hepatitis A Vaccine Revenue in 2021
3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2020-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Hepatitis A Vaccine Sales by Type
4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis A Vaccine Revenue by Type
4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis A Vaccine Price by Type
4.3.1 Global Hepatitis A Vaccine Price by Type (2017-2022)
4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION
5.1 Global Hepatitis A Vaccine Sales by Application
5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis A Vaccine Revenue by Application
5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis A Vaccine Price by Application
5.3.1 Global Hepatitis A Vaccine Price by Application (2017-2022)
5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2023-2028)
6 NORTH AMERICA
6.1 North America Hepatitis A Vaccine Market Size by Type
6.1.1 North America Hepatitis A Vaccine Sales by Type (2017-2028)
6.1.2 North America Hepatitis A Vaccine Revenue by Type (2017-2028)
6.2 North America Hepatitis A Vaccine Market Size by Application
6.3 North America Hepatitis A Vaccine Sales by Country
6.3.1 North America Hepatitis A Vaccine Sales by Country (2017-2028)
6.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
7 EUROPE
7.1 Europe Hepatitis A Vaccine Market Size by Type
7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028)
7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2028)
7.2 Europe Hepatitis A Vaccine Market Size by Application
7.3 Europe Hepatitis A Vaccine Market Size by Country
7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2028)
7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 ASIA PACIFIC
8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application
8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region
8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Southeast Asia
9 SOUTH AMERICA
9.1 South America Hepatitis A Vaccine Market Size by Type
9.1.1 South America Hepatitis A Vaccine Sales by Type (2017-2028)
9.1.2 South America Hepatitis A Vaccine Revenue by Type (2017-2028)
9.2 South America Hepatitis A Vaccine Market Size by Application
9.3 South America Hepatitis A Vaccine Market Size by Country
9.3.1 South America Hepatitis A Vaccine Sales by Country (2017-2028)
9.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028)
9.3.3 Brazil
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application
10.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country
10.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2028)
10.3.3 Middle East
10.3.4 Africa
11 CORPORATE PROFILE
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.1.4 GSK Hepatitis A Vaccine Product Introduction
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.2.4 Merck Hepatitis A Vaccine Product Introduction
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.3.4 Sanofi Hepatitis A Vaccine Product Introduction
11.3.5 Sanofi Recent Developments
11.4 Sinovac
11.4.1 Sinovac Corporation Information
11.4.2 Sinovac Overview
11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.4.4 Sinovac Hepatitis A Vaccine Product Introduction
11.4.5 Sinovac Recent Developments
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Corporation Information
11.5.2 Zhejiang Pukang Overview
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Introduction
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Corporation Information
11.6.2 Changchun Institute of Biological Overview
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Introduction
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.7.4 KM Biologics Hepatitis A Vaccine Product Introduction
11.7.5 KM Biologics Recent Developments
11.8 IMBCAMS
11.8.1 IMBCAMS Corporation Information
11.8.2 IMBCAMS Overview
11.8.3 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.8.4 IMBCAMS Hepatitis A Vaccine Product Introduction
11.9 AIM Vaccine
11.9.1 AIM Vaccine Corporation Information
11.9.2 AIM Vaccine Overview
11.9.3 AIM Vaccine Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.9.4 AIM Vaccine Hepatitis A Vaccine Product Introduction
11.9.5 AIM Vaccine Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Hepatitis A Vaccine Industry Chain Analysis
12.2 Hepatitis A Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis A Vaccine Production Mode & Process
12.4 Hepatitis A Vaccine Sales and Marketing
12.4.1 Hepatitis A Vaccine Sales Channels
12.4.2 Hepatitis A Vaccine Distributors
12.5 Hepatitis A Vaccine Customers
13 HEPATITIS A VACCINE MARKET DYNAMICS
13.1.1 Hepatitis A Vaccine Industry Trends
13.1.2 Hepatitis A Vaccine Market Drivers
13.1.3 Hepatitis A Vaccine Market Challenges
13.1.4 Hepatitis A Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL HEPATITIS A VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Live Attenuated Vaccine
Table 3. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 4. Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
Table 6. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2022)
Table 7. Global Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
Table 8. Global Hepatitis A Vaccine Sales Market Share by Region (2023-2028)
Table 9. Global Hepatitis A Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Hepatitis A Vaccine Revenue Market Share by Region (2017-2022)
Table 11. Global Hepatitis A Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 12. Global Hepatitis A Vaccine Revenue Market Share by Region (2023-2028)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us